Regular articleNeurobiologyExpression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions
Cited by (0)
Supportedby the Fondo de Investigación Sanitaria (FIS) grant PI12/02144 (C.E.); Instituto de Salud Carlos III, Ministry of Economy, Industry and Competitivity, Spain; the Fundación Salud 2000–Merk Serono, Spain grant SERONO-2013-04 (C.E.); the Red Española de Esclerosis Múltiple grant RD12/0032 (X.M.), sponsored by the FIS; and the Ajuts per donar Suport als Grups de Recerca de Catalunya grant 2014 SGR 1082 (X.M.), sponsored by the Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya, Spain.
C.C. and H.E. contributed equally to this work.
Disclosures: X.M. reports personal fees from Actelion, Bayer, Biogen, Celgene, Hoffmann-La Roche, Merck, Novartis, Oryzon Genomics, Sanofi-Genzyme, and Teva Pharmaceutical, not relevant to this work.